Literature DB >> 23213066

Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study.

Sung Keun Park1, Mi Hae Seo, Ho Cheol Shin, Jae-Hong Ryoo.   

Abstract

UNLABELLED: There have been several reports about the clinical association between type 2 diabetes mellitus (DM) and nonalcoholic fatty liver disease (NAFLD). However, most of the studies were about the unilateral effects of type 2 DM on NAFLD, and studies on the reverse relation are rare. Thus, this study was designed to investigate the effect of NAFLD on type 2 DM. We conducted a prospective cohort study on 25,232 Korean men without type 2 DM for 5 years. We serially checked the various metabolic factors including fasting glucose and hemoglobin A1c (HbA1c), and monitored the development of type 2 DM. The incidence rate of type 2 DM was compared according to the degree of NAFLD (normal, mild, and moderate to severe), and a Cox proportional hazards model was used to measure the hazard ratios (HRs) of NAFLD on type 2 DM. The incidence rate of type 2 DM increased according to the degree of NAFLD (normal: 7.0%, mild: 9.8%, moderate to severe: 17.8%, P < 0.001). Even after adjusting for other multiple covariates, the HRs (95% confidence interval [CI]) for type 2 DM development was higher in the mild group (1.09; 0.81-1.48) and moderate to severe group (1.73; 1.00-3.01) compared to the normal group, respectively (P for trend <0.001).
CONCLUSION: The development of type 2 DM is potentially more associated with more progressive NAFLD than a normal or milder state. In addition, NAFLD was an independent risk factor for the future development of type 2 DM. These results suggest the potential availability of NAFLD as an early predictor of type 2 DM.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23213066     DOI: 10.1002/hep.26183

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  42 in total

1.  Increasing prevalence of diabetes mellitus in association with fatty liver in a Japanese population.

Authors:  Yasushi Imamura; Hirofumi Uto; Yasunari Hiramine; Kaori Hosoyamada; Sho Ijuin; Shiro Yoshifuku; Hironori Miyahara; Shigeho Maenohara; Makoto Oketani; Akio Ido; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2013-10-31       Impact factor: 7.527

Review 2.  Defining comprehensive models of care for NAFLD.

Authors:  Manuel Romero-Gómez; Jörn M Schattenberg; Jeffrey V Lazarus; Quentin M Anstee; Hannes Hagström; Kenneth Cusi; Helena Cortez-Pinto; Henry E Mark; Michael Roden; Emmanuel A Tsochatzis; Vincent Wai-Sun Wong; Zobair M Younossi; Shira Zelber-Sagi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-25       Impact factor: 46.802

3.  Serum alanine aminotransferase independently correlates with intrahepatic triglyceride contents in obese subjects.

Authors:  Zheng Chen; Cheng-Kun Han; Ling-Ling Pan; Hui-Jie Zhang; Zhi-Min Ma; Zhu-Feng Huang; Shi Chen; Xiong-Jie Zhuang; Zhi-Bin Li; Xiao-Ying Li; Xue-Jun Li; Shu-Yu Yang
Journal:  Dig Dis Sci       Date:  2014-05-27       Impact factor: 3.199

4.  Beyond the liver in patients with non-alcoholic fatty liver disease (NAFLD)-cause for concern?

Authors:  Matthew J Armstrong; Geoffrey Haydon; Wing-Kin Syn
Journal:  Hepatobiliary Surg Nutr       Date:  2018-04       Impact factor: 7.293

5.  Estimation of risk for diabetes according to the metabolically healthy status stratified by degree of obesity in Korean men.

Authors:  Jae-Hong Ryoo; Sung Keun Park; Sungmin Ye; Joong-Myung Choi; Chang-Mo Oh; Sun Yong Kim; Ju-Young Shin; Jai Hyung Park; Hyun Pyo Hong; Taeg Su Ko
Journal:  Endocrine       Date:  2015-05-29       Impact factor: 3.633

6.  High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.

Authors:  Paola Portillo-Sanchez; Fernando Bril; Maryann Maximos; Romina Lomonaco; Diane Biernacki; Beverly Orsak; Sreevidya Subbarayan; Amy Webb; Joan Hecht; Kenneth Cusi
Journal:  J Clin Endocrinol Metab       Date:  2015-04-17       Impact factor: 5.958

7.  Hard clinical outcomes in patients with NAFLD.

Authors:  Ramesh Kumar
Journal:  Hepatol Int       Date:  2013-08-06       Impact factor: 6.047

Review 8.  Advancing the global public health agenda for NAFLD: a consensus statement.

Authors:  Jeffrey V Lazarus; Henry E Mark; Quentin M Anstee; Juan Pablo Arab; Rachel L Batterham; Laurent Castera; Helena Cortez-Pinto; Javier Crespo; Kenneth Cusi; M Ashworth Dirac; Sven Francque; Jacob George; Hannes Hagström; Terry T-K Huang; Mona H Ismail; Achim Kautz; Shiv Kumar Sarin; Rohit Loomba; Veronica Miller; Philip N Newsome; Michael Ninburg; Ponsiano Ocama; Vlad Ratziu; Mary Rinella; Diana Romero; Manuel Romero-Gómez; Jörn M Schattenberg; Emmanuel A Tsochatzis; Luca Valenti; Vincent Wai-Sun Wong; Yusuf Yilmaz; Zobair M Younossi; Shira Zelber-Sagi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-10-27       Impact factor: 46.802

9.  Noninvasive, Blood-Based Biomarkers as Screening Tools for Hepatic Fibrosis in People With Type 2 Diabetes.

Authors:  Angeliki Meritsi; Dimitra Latsou; Emanuel Manesis; Ilias Gatos; Ioannis Theotokas; Pavlos Zoumpoulis; Stamatia Rapti; Eustathios Tsitsopoulos; Hariklia Moshoyianni; Spilios Manolakopoulos; Dimitrios Pektasides; Anastasia Thanopoulou
Journal:  Clin Diabetes       Date:  2022

10.  Liver fat content, evaluated through semi-quantitative ultrasound measurement, is associated with impaired glucose profiles: a community-based study in Chinese.

Authors:  Xiaoming Li; Mingfeng Xia; Hui Ma; Yu Hu; Hongmei Yan; Wanyuan He; Huandong Lin; Naiqing Zhao; Jian Gao; Xin Gao
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.